>
>
Digital Psychotherapeutics Market Size By Solution (Monotherapy, Combination), By Application (Prevention, Management, Treatment), By Indication (Phobias and Anxiety, Psychotic), By Business Model (Direct-to-patients, B2B) – Global Forecast to 2032
Download Free PDF

Digital Psychotherapeutics Market
Get a free sample of this reportGet a free sample of this report Digital Psychotherapeutics Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2022
Companies covered: 10
Tables & Figures: 264
Countries covered: 22
Pages: 160
Download Free PDF
Digital Psychotherapeutics Market Size
Digital Psychotherapeutics Market size was valued at around USD 1.2 billion in 2022 and is estimated to account over USD 16.9 billion by 2032. The prevalence of psychological disorders such as depression, anxiety, and stress-related ailments is rising globally. The increased prevalence of psychological disorders is boosting the demand for accessible and effective treatment choices, thus, fueling the expansion of digital psychotherapeutics.
For instance, according to Australian Bureau of Statistics, in 2022, 21.5% of people had a 12-month mental disorder, with anxiety being the most common group (17.2% of people aged 16–85 years). In addition, according to World Health Organisation (WHO) fact sheet 2022, 1 out of every 8 individuals in this world suffers from a psychological disorder. Moreover, growing awareness of mental health concerns has reduced stigma and increased individuals' willingness to seek treatment. Individuals are becoming more self-aware of their mental health, that has substantially increased the demand for digital psychotherapeutics.
Digital psychotherapeutics are evidence-based therapy treatments and services given through digital technology and software applications. These treatments are intended to test, cure, or aid people suffering from a variety of psychological conditions, such as depression, anxiety, stress, and mood disorders.
COVID-19 Impact
The COVID-19 pandemic had a positive impact on the digital psychotherapeutics market. Due to reasons such as social isolation, economic uncertainty, and fear of the virus, the pandemic raised stress, anxiety, depression, and other mental health concerns. This spike in demand for mental health treatments resulted in a higher dependence on digital psychotherapeutics. Furthermore, the pandemic has pushed the use of remote patient monitoring and data analytics in mental health treatment. To deliver more personalised and effective therapies, digital platforms began to gather and analyse patient data.
Digital Psychotherapeutics Market Trends
The market is experiencing several notable trends that are shaping its growth and development. Factors such as increase in adoption of teletherapy, growing demand for mental health apps, and virtual reality (VR) therapy.
Digital Psychotherapeutics Market Analysis
The market by solution is categorized into monotherapy and combination therapy. The combination therapy segment garnered USD 836 million revenue in 2022.
Based on application, the digital psychotherapeutics market is segmented into prevention, management, and treatment. The treatment segment accounted for over 58.2% market share in 2022 and is anticipated to witness fastest growth during the forecast period.
Based on indication, the digital psychotherapeutics market is segmented into phobias and anxiety disorders, psychotic disorders, and other indications. The phobias and anxiety disorders segment accounted for over 42% market share in 2022.
The digital psychotherapeutics market by business model is categorized into direct-to-patients/consumers, and Business-to-Business (B2B). The direct-to-patients/consumers segment accounted for around USD 893 million revenue size in 2022.
North America digital psychotherapeutics market accounted for USD 700.3 million revenue in 2022 and is predicted to witness substantial market growth over the analysis timeline.
Digital Psychotherapeutics Market Share
The digital psychotherapeutics industry is fragmented in nature, with a large number of small and medium-sized companies competing with each other. However, there are a few larger companies that are focusing on improving their market share. Prominent players such as Pear Therapeutics, SilverCloud Health, and Woebot Health hold a notable share in the market. These companies are diligently directing their efforts towards continuous solution innovation to gain substantial market share.
Some of the eminent market participants operating in the digital psychotherapeutics industry include:
Digital Psychotherapeutics Industry News:
Digital psychotherapeutics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Solution, 2018-2032 (USD Million)
By Application, 2018-2032 (USD Million)
By Indication, 2018-2032 (USD Million)
By Business model, 2018-2032 (USD Million)
The above information is provided for the following regions and countries: